Hirschi, Marscha
Lu, Wang-Ting
Santiago-Frangos, Andrew
Wilkinson, Royce http://orcid.org/0000-0001-8831-2081
Golden, Sarah M.
Davidson, Alan R. http://orcid.org/0000-0002-0744-9199
Lander, Gabriel C. http://orcid.org/0000-0003-4921-1135
Wiedenheft, Blake http://orcid.org/0000-0001-9297-5304
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (R35GM134867, S10OD021634)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health
M.J. Murdock Charitable Trust
Article History
Received: 6 March 2020
Accepted: 7 May 2020
First Online: 1 June 2020
Competing interests
: B.W. is the founder of SurGene, LLC, and is an inventor on patent applications related to CRISPR-Cas systems and applications thereof. A.R.D. is a scientific advisory board member for Acrigen Biosciences and is an inventor on patents relating to anti-CRISPR proteins. The other authors declare no competing interests.